158 related articles for article (PubMed ID: 6698081)
1. Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I.
Fosså SD; Klepp O; Ous S; Lien HH; Stenwig AE; Abyholm T; Kaalhus O
Eur Urol; 1984; 10(1):17-23. PubMed ID: 6698081
[TBL] [Abstract][Full Text] [Related]
2. Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I.
Fosså SD; Ous S; Stenwig AE; Lien HH; Aass N; Kaalhus O
Eur Urol; 1990; 17(2):107-12. PubMed ID: 2155789
[TBL] [Abstract][Full Text] [Related]
3. Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?
Sosnowski M; Jeromin L; Płuzańska A
Int Urol Nephrol; 1994; 26(4):471-7. PubMed ID: 7528180
[TBL] [Abstract][Full Text] [Related]
4. Therapy in stage I non-seminomatous testicular tumor. A critical review of current strategies.
Weissbach L; Boedefeld EA; Oberdörster W; Vahlensieck W
Eur Urol; 1984; 10(1):1-9. PubMed ID: 6365569
[TBL] [Abstract][Full Text] [Related]
5. Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
Aass N; Fosså SD; Ous S; Lien HH; Stenwig AE; Paus E; Kaalhus O
Br J Urol; 1990 Apr; 65(4):385-90. PubMed ID: 2340372
[TBL] [Abstract][Full Text] [Related]
6. Stage II nonseminomatous testicular cancer: a 10-year experience.
Vogelzang NJ; Fraley EE; Lange PH; Torkelson J; Levitt S; Kennedy BJ
J Clin Oncol; 1983 Mar; 1(3):171-8. PubMed ID: 6668498
[TBL] [Abstract][Full Text] [Related]
7. Should chemotherapy replace retroperitoneal lymphadenectomy for clinical stage II testicular tumors?
Swanson DA
Mayo Clin Proc; 1995 Sep; 70(9):911-3. PubMed ID: 7643646
[No Abstract] [Full Text] [Related]
8. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
10. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
[TBL] [Abstract][Full Text] [Related]
12. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Sparwasser C; Treiber U; Beckert R; Pust RA
Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
[TBL] [Abstract][Full Text] [Related]
13. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
Coogan CL; Foster RS; Rowland RG; Bihrle R; Smith ER; Einhorn LH; Roth BJ; Donohue JP
Urology; 1997 Dec; 50(6):957-62. PubMed ID: 9426730
[TBL] [Abstract][Full Text] [Related]
14. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
15. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic laparoscopic retroperitoneal lymph node dissection for non seminomatous testicular tumor.
Janetschek G; Reissigl A; Peschel R; Hobisch A; Bartsch G
Ann Urol (Paris); 1995; 29(2):81-90. PubMed ID: 7646002
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of clinical staging in non-seminomatous testicular cancer--a single centre experience of retroperitoneal lymph node dissection.
Carlsson-Farrelly E; Boquist L; Ljungberg B
Scand J Urol Nephrol; 1995 Dec; 29(4):501-6. PubMed ID: 8719370
[TBL] [Abstract][Full Text] [Related]
19. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N
Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676
[TBL] [Abstract][Full Text] [Related]
20. Primary unilateral retroperitoneal lymph node dissection (RLND) in non-seminomatous testicular cancer.
Fossa SD; Ous S
Prog Clin Biol Res; 1985; 203():319. PubMed ID: 3832089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
